Brief: Gufic Biosciences Receives TGA Australia And ANVISA Brazil Approval For Parecoxib 40Mg Injection
11/09/2023 13:57
Sept 11 (Reuters) - Gufic Biosciences Ltd GUFI.NS :
* GUFIC RECEIVES TGA AUSTRALIA AND ANVISA BRAZIL APPROVAL
FOR
PARECOXIB 40MG INJECTION
Source text for Eikon: ID:nBSE2z651g
Further company coverage: GUFI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gufic Biosciences
See all newsBrief: Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility
Brief: Gufic Biosciences June-Quarter Consol Total Profit 223.1 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences posts Sept-Quarter Consol Revenue From Operations 2.37 Billion Rupees